AxoGen, Inc. (0HKD.L)
USD 15.99
(3.09%)
USD 15.99
(3.09%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 23.02 Million USD | 21.77% |
| 2022 | 18.9 Million USD | 13.25% |
| 2021 | 16.69 Million USD | 33.23% |
| 2020 | 12.52 Million USD | -9.61% |
| 2019 | 13.86 Million USD | 15.68% |
| 2018 | 11.98 Million USD | 63.78% |
| 2017 | 7.31 Million USD | 34.02% |
| 2016 | 5.45 Million USD | 38.76% |
| 2015 | 3.93 Million USD | 22.42% |
| 2014 | 3.21 Million USD | -5.44% |
| 2013 | 3.39 Million USD | 7.85% |
| 2012 | 3.15 Million USD | 78.99% |
| 2011 | 1.76 Million USD | 74.54% |
| 2010 | 1 Million USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 1.09 Million USD | 8.18% |
| 2002 | 1.01 Million USD | -33.83% |
| 2001 | 1.52 Million USD | -32.04% |
| 2000 | 2.24 Million USD | 12.38% |
| 1999 | 2 Million USD | 17.65% |
| 1998 | 1.7 Million USD | -34.62% |
| 1997 | 2.6 Million USD | 30.0% |
| 1996 | 2 Million USD | -4.76% |
| 1995 | 2.1 Million USD | 16.67% |
| 1994 | 1.8 Million USD | 100.0% |
| 1993 | 900 Thousand USD | -30.77% |
| 1992 | 1.3 Million USD | 30.0% |
| 1991 | 1 Million USD | -9.09% |
| 1990 | 1.1 Million USD | 37.5% |
| 1989 | 800 Thousand USD | 14.29% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 28.01 Million USD | 1.37% |
| 2024 Q1 | 27.63 Million USD | 20.05% |
| 2023 Q3 | 23.01 Million USD | 8.39% |
| 2023 FY | 23.02 Million USD | 21.77% |
| 2023 Q1 | 19.84 Million USD | 4.99% |
| 2023 Q2 | 21.23 Million USD | 6.99% |
| 2023 Q4 | 23.02 Million USD | 0.0% |
| 2022 FY | 18.9 Million USD | 13.25% |
| 2022 Q1 | 17.4 Million USD | 4.24% |
| 2022 Q2 | 19.22 Million USD | 10.47% |
| 2022 Q3 | 19.11 Million USD | -0.55% |
| 2022 Q4 | 18.9 Million USD | -1.1% |
| 2021 FY | 16.69 Million USD | 33.23% |
| 2021 Q1 | 13.38 Million USD | 6.86% |
| 2021 Q3 | 15.45 Million USD | 15.19% |
| 2021 Q4 | 16.69 Million USD | 8.02% |
| 2021 Q2 | 13.41 Million USD | 0.2% |
| 2020 FY | 12.52 Million USD | -9.61% |
| 2020 Q4 | 12.52 Million USD | 5.03% |
| 2020 Q1 | 14.56 Million USD | 5.06% |
| 2020 Q2 | 12.83 Million USD | -11.86% |
| 2020 Q3 | 11.92 Million USD | -7.07% |
| 2019 FY | 13.86 Million USD | 15.68% |
| 2019 Q3 | 13.68 Million USD | 0.7% |
| 2019 Q2 | 13.58 Million USD | 3.56% |
| 2019 Q1 | 13.12 Million USD | 9.5% |
| 2019 Q4 | 13.86 Million USD | 1.31% |
| 2018 Q1 | 8.05 Million USD | 10.07% |
| 2018 Q4 | 11.98 Million USD | 9.43% |
| 2018 FY | 11.98 Million USD | 63.78% |
| 2018 Q2 | 9.68 Million USD | 20.23% |
| 2018 Q3 | 10.94 Million USD | 13.09% |
| 2017 Q3 | 6.69 Million USD | 6.26% |
| 2017 Q2 | 6.3 Million USD | 7.75% |
| 2017 Q4 | 7.31 Million USD | 9.21% |
| 2017 FY | 7.31 Million USD | 34.02% |
| 2017 Q1 | 5.85 Million USD | 7.18% |
| 2016 Q2 | 4.78 Million USD | 5.99% |
| 2016 FY | 5.45 Million USD | 38.76% |
| 2016 Q3 | 4.97 Million USD | 3.85% |
| 2016 Q4 | 5.45 Million USD | 9.82% |
| 2016 Q1 | 4.51 Million USD | 14.79% |
| 2015 Q4 | 3.93 Million USD | 6.27% |
| 2015 Q2 | 3.53 Million USD | 6.05% |
| 2015 Q1 | 3.33 Million USD | 3.87% |
| 2015 FY | 3.93 Million USD | 22.42% |
| 2015 Q3 | 3.7 Million USD | 4.57% |
| 2014 Q4 | 3.21 Million USD | -3.96% |
| 2014 FY | 3.21 Million USD | -5.44% |
| 2014 Q1 | 3.46 Million USD | 1.99% |
| 2014 Q2 | 3.41 Million USD | -1.61% |
| 2014 Q3 | 3.34 Million USD | -1.89% |
| 2013 Q4 | 3.39 Million USD | -1.78% |
| 2013 Q3 | 3.46 Million USD | -3.24% |
| 2013 FY | 3.39 Million USD | 7.85% |
| 2013 Q1 | 3.42 Million USD | 8.54% |
| 2013 Q2 | 3.57 Million USD | 4.55% |
| 2012 Q2 | 2.46 Million USD | 16.06% |
| 2012 Q1 | 2.12 Million USD | 20.78% |
| 2012 FY | 3.15 Million USD | 78.99% |
| 2012 Q4 | 3.15 Million USD | 15.74% |
| 2012 Q3 | 2.72 Million USD | 10.33% |
| 2011 Q2 | - USD | -100.0% |
| 2011 Q1 | 18 Thousand USD | -98.22% |
| 2011 Q3 | 1.66 Million USD | 0.0% |
| 2011 Q4 | 1.76 Million USD | 5.91% |
| 2011 FY | 1.76 Million USD | 74.54% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | 1 Million USD | 0.0% |
| 2010 Q4 | 1 Million USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q3 | - USD | -100.0% |
| 2005 Q2 | 63.26 Thousand USD | -34.91% |
| 2005 Q1 | 97.18 Thousand USD | 0.0% |
| 2004 Q1 | 777.85 Thousand USD | -28.86% |
| 2004 Q2 | 836.86 Thousand USD | 7.59% |
| 2004 Q3 | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | -100.0% |
| 2003 Q1 | 1.16 Million USD | 15.74% |
| 2003 Q3 | 1.32 Million USD | -1.27% |
| 2003 Q4 | 1.09 Million USD | -17.64% |
| 2003 FY | 1.09 Million USD | 8.18% |
| 2003 Q2 | 1.34 Million USD | 14.94% |
| 2002 Q3 | 1.52 Million USD | 12.11% |
| 2002 Q1 | 1.61 Million USD | 0.0% |
| 2002 FY | 1.01 Million USD | -33.83% |
| 2002 Q2 | 1.35 Million USD | -15.82% |
| 2002 Q4 | 1.01 Million USD | -33.65% |
| 2001 Q3 | 1.99 Million USD | -2.82% |
| 2001 Q2 | 2.05 Million USD | -8.03% |
| 2001 Q1 | 2.23 Million USD | -2.72% |
| 2001 FY | 1.52 Million USD | -32.04% |
| 2000 Q1 | 2.34 Million USD | 11.79% |
| 2000 Q2 | 2.24 Million USD | -4.25% |
| 2000 Q3 | 2.4 Million USD | 6.98% |
| 2000 Q4 | 2.29 Million USD | -4.63% |
| 2000 FY | 2.24 Million USD | 12.38% |
| 1999 Q4 | 2.1 Million USD | 0.0% |
| 1999 Q2 | 2 Million USD | 5.26% |
| 1999 Q1 | 1.9 Million USD | 0.0% |
| 1999 FY | 2 Million USD | 17.65% |
| 1999 Q3 | 2.1 Million USD | 5.0% |
| 1998 Q4 | 1.9 Million USD | 5.56% |
| 1998 FY | 1.7 Million USD | -34.62% |
| 1998 Q1 | 1.7 Million USD | -32.0% |
| 1998 Q2 | 1.7 Million USD | 0.0% |
| 1998 Q3 | 1.8 Million USD | 5.88% |
| 1997 Q3 | 2.6 Million USD | 0.0% |
| 1997 Q2 | 2.6 Million USD | 8.33% |
| 1997 Q1 | 2.4 Million USD | 0.0% |
| 1997 FY | 2.6 Million USD | 30.0% |
| 1997 Q4 | 2.5 Million USD | -3.85% |
| 1996 Q1 | 2.1 Million USD | 0.0% |
| 1996 Q2 | 2 Million USD | -4.76% |
| 1996 Q3 | 2.2 Million USD | 10.0% |
| 1996 FY | 2 Million USD | -4.76% |
| 1996 Q4 | 2.4 Million USD | 9.09% |
| 1995 Q1 | 2.3 Million USD | -4.17% |
| 1995 Q4 | 2.1 Million USD | -12.5% |
| 1995 FY | 2.1 Million USD | 16.67% |
| 1995 Q3 | 2.4 Million USD | 14.29% |
| 1995 Q2 | 2.1 Million USD | -8.7% |
| 1994 Q3 | 2.5 Million USD | 38.89% |
| 1994 FY | 1.8 Million USD | 100.0% |
| 1994 Q1 | 1.6 Million USD | 6.67% |
| 1994 Q2 | 1.8 Million USD | 12.5% |
| 1994 Q4 | 2.4 Million USD | -4.0% |
| 1993 Q4 | 1.5 Million USD | 25.0% |
| 1993 Q1 | 1.4 Million USD | -6.67% |
| 1993 FY | 900 Thousand USD | -30.77% |
| 1993 Q3 | 1.2 Million USD | 33.33% |
| 1993 Q2 | 900 Thousand USD | -35.71% |
| 1992 Q1 | 1.6 Million USD | 14.29% |
| 1992 Q4 | 1.5 Million USD | -6.25% |
| 1992 Q2 | 1.3 Million USD | -18.75% |
| 1992 Q3 | 1.6 Million USD | 23.08% |
| 1992 FY | 1.3 Million USD | 30.0% |
| 1991 Q3 | 1.1 Million USD | 10.0% |
| 1991 Q4 | 1.4 Million USD | 27.27% |
| 1991 Q2 | 1 Million USD | -16.67% |
| 1991 Q1 | 1.2 Million USD | 9.09% |
| 1991 FY | 1 Million USD | -9.09% |
| 1990 Q3 | 1.2 Million USD | 9.09% |
| 1990 Q4 | 1.1 Million USD | -8.33% |
| 1990 FY | 1.1 Million USD | 37.5% |
| 1990 Q2 | 1.1 Million USD | -79.25% |
| 1990 Q1 | 5.3 Million USD | -10.17% |
| 1989 Q4 | 5.9 Million USD | 555.56% |
| 1989 Q3 | 900 Thousand USD | 12.5% |
| 1989 Q2 | 800 Thousand USD | 0.0% |
| 1989 FY | 800 Thousand USD | 14.29% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | 83.358% |
| Align Technology, Inc. | 296.9 Million USD | 92.247% |
| Elevance Health Inc. | -46.33 Billion USD | 100.05% |
| Boston Scientific Corporation | 2.48 Billion USD | 99.073% |
| CVS Health Corporation | 18.02 Billion USD | 99.872% |
| Cardinal Health, Inc. | 14.95 Billion USD | 99.846% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | 83.914% |
| HCA Healthcare, Inc. | 2.02 Billion USD | 98.861% |
| Hologic, Inc. | 679.8 Million USD | 96.614% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 93.947% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | 95.15% |
| Masimo Corporation | 545 Million USD | 95.776% |
| McKesson Corporation | 21.13 Billion USD | 99.891% |
| Patterson Companies, Inc. | 782.89 Million USD | 97.06% |
| Quest Diagnostics Incorporated | 190 Million USD | 87.884% |
| ResMed Inc. | 822.25 Million USD | 97.2% |
| Henry Schein, Inc. | 1.81 Billion USD | 98.732% |
| Teladoc Health, Inc. | 29.51 Million USD | 22.0% |
| Universal Health Services, Inc. | 216.98 Million USD | 89.391% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 99.185% |
| Becton, Dickinson and Company | 3.27 Billion USD | 99.297% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 98.114% |
| Danaher Corporation | 2.59 Billion USD | 99.113% |
| Stryker Corporation | 4.84 Billion USD | 99.525% |
| Medtronic plc | 5.21 Billion USD | 99.559% |